Market Cap 147.02M
Revenue (ttm) 680,000.00
Net Income (ttm) -45.43M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,680.88%
Debt to Equity Ratio 0.00
Volume 787,300
Avg Vol 944,388
Day's Range N/A - N/A
Shares Out 66.53M
Stochastic %K 36%
Beta 1.62
Analysts Strong Sell
Price Target $10.50

Company Profile

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated ongoing or planned trials in metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, and triple negative breast cancer...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 952 7570
Address:
11055 Flintkote Avenue, San Diego, United States
Bubbarayjr62
Bubbarayjr62 Oct. 25 at 12:44 PM
$CRDF New SA article: https://seekingalpha.com/article/4833398-cardiff-oncology-preparing-for-a-defining-2026
0 · Reply
Huber65
Huber65 Oct. 25 at 4:34 AM
$CRDF doesn’t matter . If data is good , stock is going up up with or with out shorts
1 · Reply
Vavavoom
Vavavoom Oct. 24 at 11:50 PM
$CRDF happy days are here again 🤫
0 · Reply
aaronr
aaronr Oct. 24 at 10:38 PM
$CRDF shorts are covering. Not surprising but kinda disappointing. Was hoping to be at 20m+ into data.
1 · Reply
look2theblue
look2theblue Oct. 24 at 10:10 PM
$CRDF Continuing higher next week. Only cap is that 200DMA just over $3.
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 8:59 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CRDF Current Share Price: $2.24 Contracts: $CRDF January 15, 2027 $5 Calls Scale in: $0.53- $0.65 Scale out: $0.82-$1.06 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
mplaster
mplaster Oct. 24 at 5:18 PM
$CRDF this has potential to explode
1 · Reply
mplaster
mplaster Oct. 24 at 4:43 PM
$CRDF all in
0 · Reply
frogman2000
frogman2000 Oct. 24 at 1:04 PM
$CRDF intraday short percentage dropped to 42% yesterday and whallah we went up. All the recent action post July is MM to suppress the PPS. They stand to make a mint when this takes off and they know it. Stay long my friends
4 · Reply
BullRun4
BullRun4 Oct. 24 at 2:54 AM
$CRDF They may announce 10 CR next week!
1 · Reply
Latest News on CRDF
Cardiff Oncology: Data Update Resolves Some Signals

Jul 30, 2025, 11:32 AM EDT - 3 months ago

Cardiff Oncology: Data Update Resolves Some Signals


Cardiff Oncology Names Roger Sidhu as Medical Chief

Jun 17, 2025, 4:39 PM EDT - 4 months ago

Cardiff Oncology Names Roger Sidhu as Medical Chief


Cardiff Oncology: Buying The First-Line Onvansertib Strategy

May 14, 2025, 9:05 AM EDT - 5 months ago

Cardiff Oncology: Buying The First-Line Onvansertib Strategy


Cardiff Oncology, Inc. (CRDF) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 9:10 PM EST - 8 months ago

Cardiff Oncology, Inc. (CRDF) Q4 2024 Earnings Call Transcript


Cardiff Oncology to Present at Upcoming Investor Conferences

Feb 24, 2025, 4:05 PM EST - 8 months ago

Cardiff Oncology to Present at Upcoming Investor Conferences


Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 11:18 AM EDT - 1 year ago

Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call Transcript


Bubbarayjr62
Bubbarayjr62 Oct. 25 at 12:44 PM
$CRDF New SA article: https://seekingalpha.com/article/4833398-cardiff-oncology-preparing-for-a-defining-2026
0 · Reply
Huber65
Huber65 Oct. 25 at 4:34 AM
$CRDF doesn’t matter . If data is good , stock is going up up with or with out shorts
1 · Reply
Vavavoom
Vavavoom Oct. 24 at 11:50 PM
$CRDF happy days are here again 🤫
0 · Reply
aaronr
aaronr Oct. 24 at 10:38 PM
$CRDF shorts are covering. Not surprising but kinda disappointing. Was hoping to be at 20m+ into data.
1 · Reply
look2theblue
look2theblue Oct. 24 at 10:10 PM
$CRDF Continuing higher next week. Only cap is that 200DMA just over $3.
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 8:59 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $CRDF Current Share Price: $2.24 Contracts: $CRDF January 15, 2027 $5 Calls Scale in: $0.53- $0.65 Scale out: $0.82-$1.06 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
mplaster
mplaster Oct. 24 at 5:18 PM
$CRDF this has potential to explode
1 · Reply
mplaster
mplaster Oct. 24 at 4:43 PM
$CRDF all in
0 · Reply
frogman2000
frogman2000 Oct. 24 at 1:04 PM
$CRDF intraday short percentage dropped to 42% yesterday and whallah we went up. All the recent action post July is MM to suppress the PPS. They stand to make a mint when this takes off and they know it. Stay long my friends
4 · Reply
BullRun4
BullRun4 Oct. 24 at 2:54 AM
$CRDF They may announce 10 CR next week!
1 · Reply
jobless44
jobless44 Oct. 23 at 4:53 PM
$CRDF we need more than 3 cents in the pocket
0 · Reply
Neba_
Neba_ Oct. 23 at 3:24 PM
$CRDF Buckle up folks, exciting time are ahead
3 · Reply
Blakeruss1
Blakeruss1 Oct. 23 at 3:04 PM
$CRDF kvro says October 29!!!!
0 · Reply
CallMeEddieMush
CallMeEddieMush Oct. 23 at 1:01 PM
$CRDF none ——dead money
0 · Reply
TheCenterOfNow
TheCenterOfNow Oct. 22 at 10:30 PM
$CRDF what catalysts do we expect in the coming months?
2 · Reply
look2theblue
look2theblue Oct. 22 at 8:49 PM
$CRDF nice recovery in an otherwise ugly market day
0 · Reply
jakeguess
jakeguess Oct. 22 at 8:28 PM
$CRDF Article talks about release coming!! What to Expect During the Q3 Update In the Q3 2025 update, Cardiff Oncology is expected to release new clinical data from its Phase 2 CRDF-004 trial for RAS-mutated metastatic colorectal cancer. I anticipate that this update will probably focus on efficacy signals, safety outcomes, and durability of response for onvansertib combined with standard therapy.
2 · Reply
jakeguess
jakeguess Oct. 22 at 8:27 PM
$CRDF https://seekingalpha.com/article/4831801-cardiff-oncologys-promising-cancer-breakthrough-ahead-why-i-choose-to-buy?utm_campaign=%7Clogin_now_link&utm_medium=email&utm_source=seeking_alpha
0 · Reply
PSDL75
PSDL75 Oct. 22 at 7:33 PM
$CRDF how has this not closed the gap
1 · Reply
GA09
GA09 Oct. 22 at 7:31 PM
$CRDF In a new article in Seeking Alpha the author states that CRDF is expected to announce new/additional data on CRDF-004 on October 29th (when they announce earnings). I do not see that anywhere and CEO has made it clear (multiple times) that they will release complete set of data in Q1 of 2026. Does anyone think otherwise? Thanks!
3 · Reply
JanetBSmellin
JanetBSmellin Oct. 22 at 7:08 PM
$CRDF Thanks for the $2.12 add
0 · Reply
frogman2000
frogman2000 Oct. 22 at 1:52 PM
$CRDF Fintel Short Squeeze score up to 83.96. The past 4 days, off exchange intraday short volume has been massive as a % of the overall volume
1 · Reply